Literature DB >> 7734044

T-cell repertoire diversity and clonal expansions in normal and clinical samples.

C Pannetier1, J Even, P Kourilsky.   

Abstract

Improved polymerase chain reaction (PCR)-based methods now permit a more in-depth analysis of the repertoire of T cells recovered in biological samples from mice and humans. At a certain level of resolution, the diversity of the T-cell repertoire can be readily estimated and clonal expansions become easily detectable. As discussed here by Christophe Pannetier, Jos Even and Philippe Kourilsky, these improvements allow a better appreciation of the degree of reproducibility of immune responses, both in mice and humans, and should have a significant impact on clinical investigations.

Entities:  

Mesh:

Year:  1995        PMID: 7734044     DOI: 10.1016/0167-5699(95)80117-0

Source DB:  PubMed          Journal:  Immunol Today        ISSN: 0167-5699


  135 in total

Review 1.  T cell receptor usage in malignant diseases.

Authors:  E Halapi; M Jeddi-Tehrani; A Osterborg; H Mellstedt
Journal:  Springer Semin Immunopathol       Date:  1999

Review 2.  Monitoring of antigen-specific cytolytic T lymphocytes in cancer patients receiving immunotherapy.

Authors:  T L Whiteside
Journal:  Clin Diagn Lab Immunol       Date:  2000-05

3.  Diversity, functionality, and stability of the T cell repertoire derived in vivo from a single human T cell precursor.

Authors:  P Bousso; V Wahn; I Douagi; G Horneff; C Pannetier; F Le Deist; F Zepp; T Niehues; P Kourilsky; A Fischer; G de Saint Basile
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

Review 4.  New methods for assessing T-cell responses.

Authors:  N Bercovici; M T Duffour; S Agrawal; M Salcedo; J P Abastado
Journal:  Clin Diagn Lab Immunol       Date:  2000-11

5.  IL-7 differentially regulates cell cycle progression and HIV-1-based vector infection in neonatal and adult CD4+ T cells.

Authors:  V Dardalhon; S Jaleco; S Kinet; B Herpers; M Steinberg; C Ferrand; D Froger; C Leveau; P Tiberghien; P Charneau; N Noraz; N Taylor
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-24       Impact factor: 11.205

6.  Immunophenotypic analysis of the TCR-Vbeta repertoire in 98 persistent expansions of CD3(+)/TCR-alphabeta(+) large granular lymphocytes: utility in assessing clonality and insights into the pathogenesis of the disease.

Authors:  M Lima; J Almeida; A H Santos; M dos Anjos Teixeira; M C Alguero; M L Queirós; A Balanzategui; B Justiça; M Gonzalez; J F San Miguel; A Orfão
Journal:  Am J Pathol       Date:  2001-11       Impact factor: 4.307

7.  Clonal expansions of CD8⁺ T cells in latently HSV-1-infected human trigeminal ganglia.

Authors:  Kathrin Held; Ingrid Eiglmeier; Susanne Himmelein; Inga Sinicina; Thomas Brandt; Diethilde Theil; Klaus Dornmair; Tobias Derfuss
Journal:  J Neurovirol       Date:  2011-12-14       Impact factor: 2.643

8.  CD95 ligand expression as a mechanism of immune escape in breast cancer.

Authors:  M Müschen; C Moers; U Warskulat; J Even; D Niederacher; M W Beckmann
Journal:  Immunology       Date:  2000-01       Impact factor: 7.397

9.  A Unique T-Cell Receptor Amino Acid Sequence Selected by Human T-Cell Lymphotropic Virus Type 1 Tax301-309-Specific Cytotoxic T Cells in HLA-A24:02-Positive Asymptomatic Carriers and Adult T-Cell Leukemia/Lymphoma Patients.

Authors:  Yuko Ishihara; Yukie Tanaka; Seiichiro Kobayashi; Koji Kawamura; Hideki Nakasone; Ayumi Gomyo; Jin Hayakawa; Masaharu Tamaki; Yu Akahoshi; Naonori Harada; Machiko Kusuda; Kazuaki Kameda; Tomotaka Ugai; Hidenori Wada; Kana Sakamoto; Miki Sato; Kiriko Terasako-Saito; Misato Kikuchi; Shun-Ichi Kimura; Aki Tanihara; Shinichi Kako; Kaoru Uchimaru; Yoshinobu Kanda
Journal:  J Virol       Date:  2017-09-12       Impact factor: 5.103

10.  Longitudinal analysis of the T-cell receptor (TCR)-VA and -VB repertoire in CD8+ T cells from individuals immunized with recombinant hepatitis B surface antigen.

Authors:  H Höhn; C Neukirch; K Freitag; A Necker; W Hitzler; B Seliger; M J Maeurer
Journal:  Clin Exp Immunol       Date:  2002-08       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.